Animalcare Group PLC banner

Animalcare Group PLC
LSE:ANCR

Watchlist Manager
Animalcare Group PLC Logo
Animalcare Group PLC
LSE:ANCR
Watchlist
Price: 332.5 GBX -0.15%
Market Cap: £229.6m

Animalcare Group PLC
Total Current Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Animalcare Group PLC
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Animalcare Group PLC
LSE:ANCR
Total Current Assets
£41.6m
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
16%
GlaxoSmithKline PLC
LSE:GSK
Total Current Assets
£17.5B
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
1%
AstraZeneca PLC
LSE:AZN
Total Current Assets
$28.7B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
6%
Hikma Pharmaceuticals PLC
LSE:HIK
Total Current Assets
$2.6B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
7%
Allergy Therapeutics PLC
LSE:AGY
Total Current Assets
£34.7m
CAGR 3-Years
-6%
CAGR 5-Years
-9%
CAGR 10-Years
0%
A
Alliance Pharma PLC
LSE:APH
Total Current Assets
£104.3m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
21%
No Stocks Found

Animalcare Group PLC
Glance View

Market Cap
229.6m GBX
Industry
Pharmaceuticals

Animalcare Group Plc engages in the development, sale, and supply of generic veterinary medicines and animal identification products. The company is headquartered in Ripon, North Yorkshire. The company went IPO on 2008-01-15. The firm is focused on developing and commercializing prescription and over-the-counter pharmaceutical products. The firm operates in three categories within the veterinary market, which includes Companion Animals, Equine and Production Animals. The company manages international supply chain, including specialist veterinary wholesalers and distributors. The firm develops, supplies and markets products and services to the veterinary profession. The company focuses on therapeutic areas, which includes pain management, dermatology and anti-infectives. The Company’s product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs.

ANCR Intrinsic Value
222.44 GBX
Overvaluation 33%
Intrinsic Value
Price GBX332.5

See Also

What is Animalcare Group PLC's Total Current Assets?
Total Current Assets
41.6m GBP

Based on the financial report for Jun 30, 2025, Animalcare Group PLC's Total Current Assets amounts to 41.6m GBP.

What is Animalcare Group PLC's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
16%

Over the last year, the Total Current Assets growth was -32%. The average annual Total Current Assets growth rates for Animalcare Group PLC have been 9% over the past three years , 7% over the past five years , and 16% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett